CANY
Caxton Associates (New York) Portfolio holdings
AUM
$3.14B
1-Year Return
47.7%
This Quarter Return
+12.24%
1 Year Return
+47.7%
3 Year Return
+76.82%
5 Year Return
+185.43%
10 Year Return
+401.35%
AUM
$1.38B
AUM Growth
+$798M
(+137%)
Cap. Flow
+$756M
Cap. Flow
% of AUM
54.76%
Top 10 Holdings %
Top 10 Hldgs %
76.55%
Holding
641
New
184
Increased
96
Reduced
106
Closed
221
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$519M |
| 2 |
iShares Biotechnology ETF
IBB
|
$152M |
| 3 |
Eli Lilly
LLY
|
$77.2M |
| 4 |
Gilead Sciences
GILD
|
$66M |
| 5 |
Invesco QQQ Trust
QQQ
|
$15.1M |
Top Sells
| 1 |
Amazon
AMZN
|
$18.1M |
| 2 |
Broadcom
AVGO
|
$16.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$15.8M |
| 4 |
Marvell Technology
MRVL
|
$14.3M |
| 5 |
T-Mobile US
TMUS
|
$13M |
Sector Composition
| 1 | Healthcare | 28.19% |
| 2 | Technology | 4.36% |
| 3 | Financials | 4.26% |
| 4 | Consumer Discretionary | 3.14% |
| 5 | Communication Services | 1.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Infosys
INFY
$67.9B
| $760K | 0.05% |
42,199
-33,631
| -44% | -$606K |
|
152
Graco
GGG
$14.2B
| $758K | 0.05% |
11,277
+2,857
| +34% | +$192K |
|
|
JOYY
153
JOYY Inc. American Depositary Shares
JOYY
$3.21B
| $756K | 0.05% |
23,947
+6,348
| +36% | +$201K |
|
154
Ardmore Shipping
ASC
$490M
| $755K | 0.05% |
52,390
-19,666
| -27% | -$283K |
|
155
CVS Health
CVS
$93.6B
| $747K | 0.05% |
+8,015
| New | +$747K |
|
|
AAN
156
DELISTED
The Aaron's Company, Inc.
AAN
| $747K | 0.05% |
62,473
+33,166
| +113% | +$396K |
|
157
Fossil Group
FOSL
$165M
| $743K | 0.05% |
172,372
+52,960
| +44% | +$228K |
|
158
OraSure Technologies
OSUR
$236M
| $742K | 0.05% |
153,879
| – | – |
|
159
Broadridge
BR
$29.4B
| $737K | 0.05% |
+5,496
| New | +$737K |
|
160
Global Payments
GPN
$21.3B
| $732K | 0.05% |
7,372
+5,417
| +277% | +$538K |
|
161
Teradyne
TER
$19.1B
| $722K | 0.05% |
8,264
-9,562
| -54% | -$835K |
|
162
Ziff Davis
ZD
$1.56B
| $721K | 0.05% |
9,111
-2,855
| -24% | -$226K |
|
163
West Pharmaceutical
WST
$18B
| $715K | 0.05% |
3,036
+1,519
| +100% | +$357K |
|
164
Leslie's
LESL
$64.6M
| $711K | 0.05% |
+58,237
| New | +$711K |
|
165
Ford
F
$46.7B
| $709K | 0.05% |
60,968
+888
| +1% | +$10.3K |
|
166
Immersion
IMMR
$230M
| $691K | 0.05% |
98,243
+87,112
| +783% | +$612K |
|
167
NetEase
NTES
$85B
| $688K | 0.05% |
+9,474
| New | +$688K |
|
168
Entegris
ENTG
$12.4B
| $684K | 0.05% |
+10,435
| New | +$684K |
|
169
Harmonic Inc
HLIT
$1.14B
| $683K | 0.05% |
+52,172
| New | +$683K |
|
170
ResMed
RMD
$40.6B
| $674K | 0.05% |
+3,240
| New | +$674K |
|
171
Xerox
XRX
$493M
| $661K | 0.04% |
45,285
| – | – |
|
172
Performance Food Group
PFGC
$16.5B
| $661K | 0.04% |
+11,312
| New | +$661K |
|
173
Atara Biotherapeutics
ATRA
$90.7M
| $655K | 0.04% |
7,987
+106
| +1% | +$8.69K |
|
|
ALLK
174
DELISTED
Allakos
ALLK
| $655K | 0.04% |
77,773
| – | – |
|
175
Marsh & McLennan
MMC
$100B
| $654K | 0.04% |
+3,954
| New | +$654K |
|